ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)
Close on Nov 13, 2026Market cap $271.82MP/E –Yield –
ClearPoint Neuro gross margin
Gross margin is gross profit as a percentage of revenue.
ClearPoint Neuro's gross margin for the twelve months ending Sep 30, 2026 was 61.4%. For fiscal 2025 it was 61.4%, against 60.9% the year before. The highest annual figure on record is 99.4% in fiscal 2010.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 61.4% | +0.5 |
| FY2024 | Dec 31, 2024 | 60.9% | +4.1 |
| FY2023 | Dec 31, 2023 | 56.8% | −9.0 |
| FY2022 | Dec 31, 2022 | 65.8% | −2.4 |
| FY2021 | Dec 31, 2021 | 68.2% | −2.8 |
| FY2020 | Dec 31, 2020 | 71.1% | +6.2 |
| FY2019 | Dec 31, 2019 | 64.9% | −2.1 |
| FY2018 | Dec 31, 2018 | 66.9% | +6.2 |
| FY2017 | Dec 31, 2017 | 60.7% | +6.7 |
| FY2016 | Dec 31, 2016 | 54.0% | −2.7 |
| FY2015 | Dec 31, 2015 | 56.7% | +10.2 |
| FY2014 | Dec 31, 2014 | 46.5% | −17.3 |
| FY2013 | Dec 31, 2013 | 63.8% | −25.2 |
| FY2012 | Dec 31, 2012 | 89.0% | +6.2 |
| FY2011 | Dec 31, 2011 | 82.8% | −16.6 |
| FY2010 | Dec 31, 2010 | 99.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 58.5% | −4.7 |
| Q2 FY2026 | Jun 30, 2026 | 61.7% | +1.4 |
| Q1 FY2026 | Mar 31, 2026 | 64.0% | +3.5 |
| Q4 FY2025 | Dec 31, 2025 | 61.5% | +0.2 |
| Q3 FY2025 | Sep 30, 2025 | 63.2% | +3.5 |
| Q2 FY2025 | Jun 30, 2025 | 60.3% | −3.2 |
| Q1 FY2025 | Mar 31, 2025 | 60.5% | +1.2 |
| Q4 FY2024 | Dec 31, 2024 | 61.3% | +2.4 |
| Q3 FY2024 | Sep 30, 2024 | 59.7% | +2.9 |
| Q2 FY2024 | Jun 30, 2024 | 63.5% | +10.9 |
| Q1 FY2024 | Mar 31, 2024 | 59.2% | +0.3 |
| Q4 FY2023 | Dec 31, 2023 | 58.9% | −6.1 |
| Q3 FY2023 | Sep 30, 2023 | 56.8% | −14.7 |
| Q2 FY2023 | Jun 30, 2023 | 52.5% | −10.1 |
| Q1 FY2023 | Mar 31, 2023 | 58.9% | −5.3 |
| Q4 FY2022 | Dec 31, 2022 | 65.1% | −9.3 |
| Q3 FY2022 | Sep 30, 2022 | 71.5% | +5.0 |
| Q2 FY2022 | Jun 30, 2022 | 62.6% | −4.0 |
| Q1 FY2022 | Mar 31, 2022 | 64.2% | −0.6 |
| Q4 FY2021 | Dec 31, 2021 | 74.4% | +3.2 |
| Q3 FY2021 | Sep 30, 2021 | 66.5% | −7.9 |
| Q2 FY2021 | Jun 30, 2021 | 66.6% | −1.0 |
| Q1 FY2021 | Mar 31, 2021 | 64.9% | −5.2 |
| Q4 FY2020 | Dec 31, 2020 | 71.1% | +3.6 |
| Q3 FY2020 | Sep 30, 2020 | 74.3% | +7.9 |
| Q2 FY2020 | Jun 30, 2020 | 67.6% | +7.2 |
| Q1 FY2020 | Mar 31, 2020 | 70.1% | +5.9 |
| Q4 FY2019 | Dec 31, 2019 | 67.5% | −2.2 |
| Q3 FY2019 | Sep 30, 2019 | 66.4% | −3.0 |
| Q2 FY2019 | Jun 30, 2019 | 60.5% | −2.9 |
| Q1 FY2019 | Mar 31, 2019 | 64.1% | +0.4 |
| Q4 FY2018 | Dec 31, 2018 | 69.7% | +9.0 |
| Q3 FY2018 | Sep 30, 2018 | 69.4% | +9.5 |
| Q2 FY2018 | Jun 30, 2018 | 63.4% | +3.8 |
| Q1 FY2018 | Mar 31, 2018 | 63.7% | +1.2 |
| Q4 FY2017 | Dec 31, 2017 | 60.8% | +2.2 |
| Q3 FY2017 | Sep 30, 2017 | 59.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 59.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 62.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 58.6% | – |
See a number that looks wrong?